Nusinersen Shows Efficacy in Infantile- and Late-Onset Spinal Muscular Atrophy

The new data further cemented the therapy’s consistent safety profile from previous studies as well as demonstrated a newfound durability in patients with later-onset spinal muscular atrophy. 

from Front page feed https://ift.tt/3dhFyoA